LUNESTA is indicated for the treatment of insomnia. In controlled outpatient and sleep laboratory studies. LUNESTA administered at bedtime decreased sleep latency and improved sleep maintenance. The clinical trials performed in support of efficacy…

Spironolactone has been shown to be a tumorigen in chronic toxicity studies in rats (see PRECAUTIONS. section). Spironolactone and hydrochlorothiazide tablets should be used only in those conditions described below. Unnecessary use of this drug…